TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Revenue minus cost of goods sold
3Y CAGR
-13.3%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.84M | +213.7% |
| 2024 | $2.82M | -86.6% |
| 2023 | $21.05M | +55.5% |
| 2022 | $13.54M | +33.5% |
| 2021 | $10.14M | +152.0% |
| 2020 | $-19.49M | -106.4% |
| 2019 | $-9.44M | - |